179 related articles for article (PubMed ID: 31327462)
1. Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated β-Catenin Activation.
Zhang W; Su X; Li S; Wang Y; Wang Q; Zeng H
Am J Med Sci; 2019 Sep; 358(3):227-234. PubMed ID: 31327462
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting the MNK-eIF4E-β-catenin axis increases the responsiveness of aggressive breast cancer cells to chemotherapy.
Li Z; Sun Y; Qu M; Wan H; Cai F; Zhang P
Oncotarget; 2017 Jan; 8(2):2906-2915. PubMed ID: 27926520
[TBL] [Abstract][Full Text] [Related]
3. Targeting of the MNK-eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function.
Lim S; Saw TY; Zhang M; Janes MR; Nacro K; Hill J; Lim AQ; Chang CT; Fruman DA; Rizzieri DA; Tan SY; Fan H; Chuah CT; Ong ST
Proc Natl Acad Sci U S A; 2013 Jun; 110(25):E2298-307. PubMed ID: 23737503
[TBL] [Abstract][Full Text] [Related]
4. Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin.
Xu Y; Liao S; Wang L; Wang Y; Wei W; Su K; Tu Y; Zhu S
Cancer Chemother Pharmacol; 2021 Jan; 87(1):85-93. PubMed ID: 33159561
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of eukaryotic initiation factor 4E phosphorylation by cercosporamide selectively suppresses angiogenesis, growth and survival of human hepatocellular carcinoma.
Liu Y; Sun L; Su X; Guo S
Biomed Pharmacother; 2016 Dec; 84():237-243. PubMed ID: 27662474
[TBL] [Abstract][Full Text] [Related]
6. Inhibition MNK-eIF4E-β-catenin preferentially sensitizes gastric cancer to chemotherapy.
Yang X; Liu Z; Yin X; Zeng Y; Guo G
Fundam Clin Pharmacol; 2022 Aug; 36(4):712-720. PubMed ID: 35048413
[TBL] [Abstract][Full Text] [Related]
7. Targeting of MNK/eIF4E overcomes chemoresistance in cervical cancer.
Zhu Y; Wang C; Li M; Yang X
J Pharm Pharmacol; 2021 Sep; 73(10):1418-1426. PubMed ID: 34254647
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic inhibition of MAP kinase interacting kinase blocks eukaryotic initiation factor 4E phosphorylation and suppresses outgrowth of experimental lung metastases.
Konicek BW; Stephens JR; McNulty AM; Robichaud N; Peery RB; Dumstorf CA; Dowless MS; Iversen PW; Parsons S; Ellis KE; McCann DJ; Pelletier J; Furic L; Yingling JM; Stancato LF; Sonenberg N; Graff JR
Cancer Res; 2011 Mar; 71(5):1849-57. PubMed ID: 21233335
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic drug rifabutin is effective against lung cancer cells by targeting the eIF4E-β-catenin axis.
Li J; Huang Y; Gao Y; Wu H; Dong W; Liu L
Biochem Biophys Res Commun; 2016 Apr; 472(2):299-305. PubMed ID: 26944016
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of mammalian target of rapamycin induces phosphatidylinositol 3-kinase-dependent and Mnk-mediated eukaryotic translation initiation factor 4E phosphorylation.
Wang X; Yue P; Chan CB; Ye K; Ueda T; Watanabe-Fukunaga R; Fukunaga R; Fu H; Khuri FR; Sun SY
Mol Cell Biol; 2007 Nov; 27(21):7405-13. PubMed ID: 17724079
[TBL] [Abstract][Full Text] [Related]
12. Suppression Of β-catenin Nuclear Translocation By CGP57380 Decelerates Poor Progression And Potentiates Radiation-Induced Apoptosis in Nasopharyngeal Carcinoma.
Wang W; Wen Q; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Li J; Zhou J; Fan S
Theranostics; 2017; 7(7):2134-2149. PubMed ID: 28656063
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evidence that MNK/eIF4E inhibition by cercosporamide enhances the response to antiangiogenic TKI and mTOR inhibitor in renal cell carcinoma.
Chen S; Cui L; Hu Q; Shen Y; Jiang Y; Zhao J
Biochem Biophys Res Commun; 2020 Sep; 530(1):142-148. PubMed ID: 32828276
[TBL] [Abstract][Full Text] [Related]
14. Antiviral Drug Ribavirin Targets Thyroid Cancer Cells by Inhibiting the eIF4E-β-Catenin Axis.
Shen X; Zhu Y; Xiao Z; Dai X; Liu D; Li L; Xiao B
Am J Med Sci; 2017 Aug; 354(2):182-189. PubMed ID: 28864377
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of MNK pathways enhances cancer cell response to chemotherapy with temozolomide and targeted radionuclide therapy.
Grzmil M; Seebacher J; Hess D; Behe M; Schibli R; Moncayo G; Frank S; Hemmings BA
Cell Signal; 2016 Sep; 28(9):1412-1421. PubMed ID: 27289018
[TBL] [Abstract][Full Text] [Related]
16. CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway.
Wen Q; Wang W; Luo J; Chu S; Chen L; Xu L; Zang H; Alnemah MM; Ma J; Fan S
Oncotarget; 2016 May; 7(19):27787-801. PubMed ID: 27050281
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Mnk-eIF4E pathway sensitizes the efficacy to chemotherapy in anaplastic thyroid cancer.
Hu K; Zhang J; Yu M; Xiong C
Future Oncol; 2017 Mar; 13(6):489-498. PubMed ID: 27785922
[TBL] [Abstract][Full Text] [Related]
18. First MNKs degrading agents block phosphorylation of eIF4E, induce apoptosis, inhibit cell growth, migration and invasion in triple negative and Her2-overexpressing breast cancer cell lines.
Ramalingam S; Gediya L; Kwegyir-Afful AK; Ramamurthy VP; Purushottamachar P; Mbatia H; Njar VC
Oncotarget; 2014 Jan; 5(2):530-43. PubMed ID: 24504069
[TBL] [Abstract][Full Text] [Related]
19. Targeting the eIF4E/β-catenin axis sensitizes cervical carcinoma squamous cells to chemotherapy.
Xu H; Wang Z; Xu L; Mo G; Duan G; Wang Y; Sun Z; Chen H
Am J Transl Res; 2017; 9(3):1203-1212. PubMed ID: 28386346
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting ERK/Mnk/eIF4E broadly sensitizes ovarian cancer response to chemotherapy.
Liu S; Zha J; Lei M
Clin Transl Oncol; 2018 Mar; 20(3):374-381. PubMed ID: 28766096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
